Technology
CRISPR-Based Biosensors for Real-Time Pathogen Detection
Quick fact
COVID-19 testing kits based on CRISPR, such as SHERLOCK and DETECTR, can deliver results in under an hour with minimal equipment, and some can even be used with a simple paper strip, much like a pregnancy test.
Why this is interesting
Imagine being able to detect a virus in a drop of blood within minutes, using a tool that was originally designed to edit genes. That's the promise of CRISPR-based biosensors—a technology that turns the gene-snipping machinery of bacteria into a rapid pathogen-spotting device.
Read the full explanation
Understanding CRISPR-Based Biosensors for Real-Time Pathogen Detection
To understand CRISPR-based biosensors, start with what CRISPR is: a natural system in bacteria that defends against viruses. It uses a protein called Cas, guided by a short piece of RNA, to find and cut specific DNA or RNA sequences. In gene editing, scientists exploit this to cut and modify genes. But the same targeting ability can be used for detection. In a biosensor, the guide RNA is designed to match a unique sequence from a pathogen, like a virus. When the biosensor sample contains that pathogen's genetic material, the guide RNA binds to it, and the Cas protein is activated. Importantly, some Cas proteins (like Cas12 and Cas13) don't just cut the target—they then go into a 'collateral' mode, chopping up any single-stranded DNA or RNA nearby. In a biosensor, the reaction mixture includes reporter molecules—short pieces of nucleic acid with a fluorescent tag or a label that can be captured on a test strip. When the Cas protein is activated, it cleaves these reporters indiscriminately, producing a measurable signal. If the pathogen is absent, the Cas protein stays quiet, and no signal is generated. This provides a simple, yes/no answer for the presence of the pathogen. This mechanism is the basis of real-time detection because the reaction happens at a constant temperature (often around body temperature) and can be monitored optically or with a lateral flow strip, eliminating the need for expensive lab equipment.
A deeper explanation
The power of CRISPR-based biosensors lies in their high specificity and programmability. The guide RNA can be designed to target almost any nucleic acid sequence, allowing rapid development of biosensors for emerging pathogens. The collateral cleavage activity of Cas12 and Cas13 is key: it amplifies the single target-binding event into thousands of cleavage events on reporter molecules, yielding a strong signal. This amplification is 'un triggered' by the presence of the target, enabling sensitivity comparable to or better than traditional PCR, but without the need for thermal cycling. Real-time detection is achieved by measuring the fluorescence increase or color change over time as the reaction proceeds. This allows quantitative or semi-quantitative measurement of pathogen load. The reaction is isothermal and can be performed in a single tube, making the system highly compatible with point-of-care devices. The integration of CRISPR biosensors with microfluidics and smartphone-based readers further enables portable, real-time monitoring. Applications include diagnosing viral infections (e.g., SARS-CoV-2, Zika), detecting bacterial pathogens, and even identifying genetic mutations. The main challenges are ensuring specificity in complex biological samples, avoiding non-specific activation, and developing robust lyophilized reagents for field use. Nonetheless, this technology promises to democratize molecular diagnostics, making rapid, accurate disease detection accessible in low-resource settings and during outbreaks.